From the AFR today
Mr Wong said that he would continue to pursue three key strategic goals: expanding the use of Sirtex's SIR-Spheres product in primary and secondary liver cancers, research and development, and mergers and acquisitions.
Read more: http://www.copyright link/business/...g-shares-higher-20150813-giy3a8#ixzz3ihmKZMuq
Follow us: @FinancialReview on Twitter | financialreview on Facebook
Does anyone know anything about points 2 and 3?
Taken from the 2020 vision slide in the investor presentation (slide 18)
R&D includes Carbon Cage Technology - I haven't found much published/available in the last couple years. and Radioprotector project and Nanoparticles Development.
Any rumours or ideas discussion about mergers and acquisitions?
Add to My Watchlist
What is My Watchlist?